Ann Arbor, Mich.-based Micro-Tech Endoscopy and Northbridge, Mass.-based Interscope Inc. have inked a deal to collaborate and distribute the EndoRotor System for interventional gastroenterology.
“Micro-Tech’s position as a market disruptor with strong leadership provides significant scale to the Interscope team. Our innovative product, paired with the driving force of Micro-Tech, will dramatically accelerate physician access to the EndoRotor and the benefits it provides,” explains Jeffery Ryan, co-founder, president, and CEO of Interscope, Inc.
“Our shared drive to deliver innovation to customers brought Micro-Tech Endoscopy and Interscope together,” adds Chris Li, president of Micro-Tech Endoscopy USA. “We are extremely excited about this partnership and the benefits it brings to patients.”
This extended clearance makes the EndoRotor the first FDA-cleared device used in direct endoscopic necrosectomy for walled-off pancreatic necrosis/walled-off necrosis. “We want to thank the hospitals, clinicians, and staff who were involved in our recent clinical trial, as well as those who contributed to our real-world data collection. Without your efforts, this clearance and clinical validation would not have been possible,” Ryan says.
